Alnajashi, Hind. 2025. “Rituximab As an off Label, High Efficacy Therapy in The Treatment of Multiple Sclerosis and Related Central Nervous System Demyelinating Diseases: Single Centre Experience and Literature Review”. Journal of Contemporary Medical Sciences 11 (3). https://doi.org/10.22317/jcms.v11i3.1892.